AIMS Medical Science | |
A meta-analysis to estimate the incidence of thromboembolism in hospitalized COVID-19 patients | |
article | |
Ayema Haque1  Areeba Minhaj1  Areeba Ahmed1  Owais Khan1  Palvisha Qasim1  Hasan Fareed1  Fatima Nazir1  Ayesha Asghar1  Kashif Ali1  Sobia Mansoor1  | |
[1] Department of Internal Medicine, Dow University of Health Sciences | |
关键词: COVID-19; SARS-CoV-2; thromboembolism; meta-analysis; pulmonary embolism; stroke; myocardial infarction; deep venous thrombosis; ; | |
DOI : 10.3934/medsci.2020020 | |
来源: American Institute of Mathematical Sciences | |
【 摘 要 】
Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous and arterial thrombosis in patients. Numerous studies have been conducted on COVID-19 and its association with thromboembolism is well known. We conducted a meta-analysis to find out the incidence of thromboembolism in hospitalised patients with COVID-19 to provide more generalized results. A systematic literature search was conducted in PubMed and SCOPUS to find observational studies reporting outcomes of interest. Amongst the studied thromboembolic events, the meta-analysis showed the prevalence of pulmonary embolism (PP: 12.4% [7.2%, 18.6%]; I2 = 97.23%) to be the highest. It was followed by deep vein thrombosis (PP: 8.6% [4.2%, 14.3%]; I2 = 97.52%), myocardial infarction (PP: 2.3% [0.2%, 11.2%]; I2 = 99.3%), and stroke (PP: 1.2% [0.8%, 1.6%]; I2 = 65.09%). The results of this analysis further warrant the timely and appropriate use of pharmacological thromboprophylaxis and identification of risk factors in hospitalized COVID-19 patients.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202106050001037ZK.pdf | 869KB | download |